CM/TNS/24/5713 - NHS Framework for Transition products - 1 February 2025
Estimated value
£9.9m
Awarded value
£9.9m
Suppliers
1
Lots
1
Published
21 Jan 2025
Description
Project title: NHS National Framework for Transition products commencing 1 February 2025 Offer reference number: CM/TNS/24/5713 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months. Potential periods of call-offs under the framework agreement: CM/TNS/24/5713/01 - Eribulin Injection, Bosutinib Tablets and Liraglutide Injection Lot 1 CESW: 01/02/2025 to 31/05/2026 (16 months) Lot 2 LSNE: 01/02/2025 to 31/05/2026 (16 months) Lot 3 NWLN: 01/02/2025 to 31/05/2026 (16 months) Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
Scope
- Reference
- CF-2796900D0O000000rwimUAA
- Total value
- £9,867,000 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
- 01 Feb 2025 to 30 May 2026
- CPV classifications
- 33600000
- Particular suitability
- Small and medium-sized enterprises (SME)
Submission & procedure
- Submission deadline
- 18 Nov 2024, 1:00 pm
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£9.9m
Award date
14 Jan 2025
Contract start
01 Feb 2025
Contract end
30 May 2026